What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His main research concerns Catalysis, Cancer research, Internal medicine, Pharmacology and Cancer.
His research integrates issues of Inorganic chemistry and Adsorption in his study of Catalysis.
The concepts of his Cancer research study are interwoven with issues in Downregulation and upregulation, Gene, Gene knockdown, Bioinformatics and Ovarian cancer.
His Internal medicine research includes elements of Endocrinology, Oncology and Pharmacogenetics.
In his research, Hydroxylation is intimately related to Pharmacognosy, which falls under the overarching field of Pharmacology.
His research in Cancer intersects with topics in Transforming growth factor beta, Intracellular and Function.
His most cited work include:
- Autophagy is a therapeutic target in anticancer drug resistance (274 citations)
- Biodiesel production from algae oil high in free fatty acids by two-step catalytic conversion. (241 citations)
- Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV. (195 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Pharmacology, Cancer research, Oncology and Endocrinology.
As part of one scientific family, he deals mainly with the area of Internal medicine, narrowing it down to issues related to the Genotype, and often Allele.
Specifically, his work in Pharmacology is concerned with the study of Pharmacokinetics.
His study of Pharmacodynamics is a part of Pharmacokinetics.
His research integrates issues of Carcinogenesis, Cancer, Metastasis, Gene and Apoptosis in his study of Cancer research.
His research in Oncology is mostly concerned with Lung cancer.
He most often published in these fields:
- Internal medicine (26.07%)
- Pharmacology (16.67%)
- Cancer research (10.90%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (26.07%)
- Cancer research (10.90%)
- Oncology (8.76%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cancer research, Oncology, Cancer and Pharmacology.
His Internal medicine research focuses on Genotype and how it connects with Allele.
As a part of the same scientific family, he mostly works in the field of Cancer research, focusing on Apoptosis and, on occasion, Cisplatin.
The Oncology study which covers Chemotherapy that intersects with Lung cancer.
His studies in Cancer integrate themes in fields like Gene expression and Gene.
The Pharmacology study combines topics in areas such as Metformin, Organic cation transport proteins and In vivo.
Between 2017 and 2021, his most popular works were:
- Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV. (195 citations)
- Nanoparticles of Chlorin Dimer with Enhanced Absorbance for Photoacoustic Imaging and Phototherapy (53 citations)
- The dysregulation of tRNAs and tRNA derivatives in cancer. (36 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Wei Zhang mainly focuses on Cancer research, Internal medicine, Apoptosis, Oncology and Carcinogenesis.
The study incorporates disciplines such as Microarray analysis techniques, Metastasis, A549 cell and DNA repair in addition to Cancer research.
Wei Zhang has included themes like Diabetes mellitus and Type 2 diabetes in his Internal medicine study.
His Apoptosis study combines topics in areas such as Oxidative stress, Cisplatin, Function, Signal transduction and Mitochondrion.
Wei Zhang interconnects Chemotherapy, Lymphoblastic Leukemia, Thiopurine methyltransferase, Pharmacogenomic Variants and Long non-coding RNA in the investigation of issues within Oncology.
Carcinogenesis is a subfield of Cancer that he explores.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
